IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN THE ABSENCE OF SIGNIFICANT SYMPTOMS - RHYTHM DIAGNOSIS AND MANAGEMENT AIDED BY STORED ELECTROGRAM ANALYSIS

被引:98
作者
HOOK, BG
CALLANS, DJ
KLEIMAN, RB
FLORES, BT
MARCHLINSKI, FE
机构
[1] Cardiology Division, Founders Pavilion, Pennsylvania University Hospital, Philadelphia, PA 19104
关键词
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR ELECTROGRAM STORAGE;
D O I
10.1161/01.CIR.87.6.1897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. Methods and Results. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four, T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. Conclusions. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.
引用
收藏
页码:1897 / 1906
页数:10
相关论文
共 27 条
  • [11] AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - INADVERTENT DISCHARGES DURING PERMANENT PACEMAKER MAGNET TESTS
    KIM, SG
    FURMAN, S
    MATOS, JA
    WASPE, LE
    BRODMAN, R
    FISHER, JD
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (03): : 579 - 582
  • [12] ANTITACHYCARDIA DEVICES - REALITIES AND PROMISES
    KLEIN, LS
    MILES, WM
    ZIPES, DP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (05) : 1349 - 1362
  • [13] REDUCTION IN DEFIBRILLATOR SHOCKS WITH AN IMPLANTABLE DEVICE COMBINING ANTITACHYCARDIA PACING AND SHOCK THERAPY
    LEITCH, JW
    GILLIS, AM
    WYSE, DG
    YEE, R
    KLEIN, GJ
    GUIRAUDON, G
    SHELDON, RS
    DUFF, HJ
    KIESER, TM
    MITCHELL, LB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (01) : 145 - 151
  • [14] PREDICTORS OF 1ST DISCHARGE AND SUBSEQUENT SURVIVAL IN PATIENTS WITH AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    LEVINE, JH
    MELLITS, D
    BAUMGARDNER, RA
    VELTRI, EP
    MOWER, M
    GRUNWALD, L
    GUARNIERI, T
    AARONS, D
    GRIFFITH, LSC
    [J]. CIRCULATION, 1991, 84 (02) : 558 - 566
  • [15] CLINICAL-PERFORMANCE OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - ELECTROCARDIOGRAPHIC DOCUMENTATION OF 101 SPONTANEOUS DISCHARGES
    MALONEY, J
    MASTERSON, M
    KHOURY, D
    TROHMAN, R
    WILKOFF, B
    SIMMONS, T
    MORANT, V
    CASTLE, L
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (02): : 280 - 285
  • [16] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS, AND DEVICE FAILURES
    MARCHLINSKI, FE
    FLORES, BT
    BUXTON, AE
    HARGROVE, WC
    ADDONIZIO, VP
    STEPHENSON, LW
    HARKEN, AH
    DOHERTY, JU
    GROGAN, EW
    JOSEPHSON, ME
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) : 481 - 488
  • [17] MARCHLINSKI FE, 1990, CARDIAC PACING ELECT, P743
  • [18] TERMINATION OF MALIGNANT VENTRICULAR ARRHYTHMIAS WITH AN IMPLANTED AUTOMATIC DEFIBRILLATOR IN HUMAN-BEINGS
    MIROWSKI, M
    REID, PR
    MOWER, MM
    WATKINS, L
    GOTT, VL
    SCHAUBLE, JF
    LANGER, A
    HEILMAN, MS
    KOLENIK, SA
    FISCHELL, RE
    WEISFELDT, ML
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (06) : 322 - 324
  • [19] TIME TO 1ST SHOCK AND CLINICAL OUTCOME IN PATIENTS RECEIVING AN AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    MYERBURG, RJ
    LUCERI, RM
    THURER, R
    COOPER, DK
    ZAMAN, L
    INTERIAN, A
    FERNANDEZ, P
    COX, M
    GLICKSMAN, F
    CASTELLANOS, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (02) : 508 - 514
  • [20] OLSON WH, 1986, COMPUT CARDIOL, P167